An 8-week, double-blind, placebo-controled, multicenter, Ambulatory Blood Pressure Monitoring (ABPM) study of Teveten (Eprosartan Mesylate) 600mg and 1200mg QD in patients with essential hypertension

✍ Scribed by Henry A. Punzi; Connie F. Punzi

• Book ID: 116208883
• Publisher: Nature Publishing Group
• Year: 2005
• Tongue: English
• Weight: 61 KB
• Volume: 18
• Category: Article
• ISSN: 0895-7061
• DOI: 10.1016/j.amjhyper.2005.03.259